WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Arbutus Biopharma earnings were $153.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ABUS earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$5.1M, down 103% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ABUS reported annual earnings of -$33.5M, with -52.1% growth. The next ABUS earnings date is Nov 12, 2026.

ABUS earnings history

Current Revenue
$181.7M
Current Earnings
$153.1M
Current Profit Margin
84.2%

ABUS Return on Equity

Current Company
91%
Current Industry
-10.8%
Current Market
30.9%
ABUS's Return on Equity (91%)... subscribe to Premium to read more.
High Return on Equity Performance

ABUS Return on Assets

Current Company
82.3%
Current Industry
-10.6%
ABUS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABUS announces earnings.

ABUS Return on Capital Employed

Current Company
56.58%
Current Industry
-7.4%
ABUS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABUS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABUS$153.17M$153.05MN/A$0.80
KURA-$293.98M-$296.78MN/A-$3.37
ODTXN/AN/AN/AN/A
ALMS-$435.02M-$438.96MN/A-$3.85
CRVS-$54.01M-$54.13MN/A-$0.61
View Top Biotech Stocks

ABUS earnings dates

Next earnings date
Nov 12, 2026

Arbutus Biopharma Earnings Reports & History FAQ

What were Arbutus Biopharma's earnings last quarter?

On ABUS's earnings call on Aug 12, 2026, Arbutus Biopharma (NASDAQ: ABUS) reported Q2 2026 earnings per share (EPS) of -$0.03, up 400% year over year. Total ABUS earnings for the quarter were -$5.14 million. In the same quarter last year, Arbutus Biopharma's earnings per share (EPS) was $0.01.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.

When does Arbutus Biopharma report earnings?

The next ABUS earnings call is Nov 12, 2026. Add ABUS to your watchlist to be reminded of Arbutus Biopharma's next earnings date.

What was ABUS's earnings growth in the past year?

As of Arbutus Biopharma's earnings date in Aug 12, 2026, Arbutus Biopharma's earnings has grown year over year. ABUS earnings in the past year totalled $153.05 million.

Is Arbutus Biopharma profitable or losing money?

As of the last Arbutus Biopharma earnings report, Arbutus Biopharma is currently profitable. Arbutus Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $153.05 million, a 382.12% decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.